Navigation Links
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome

ducts

Forest Laboratories (www.frx.com) is a US-based pharmaceutical company dedicated to identifying, developing and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R) (olmesartan medoxomil- hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.

    * Benicar is a registered trademark of Daiichi Sankyo, Inc., and Campral

      is a registered trademark of Merck Sante s.a.s., subsidiary of Merck

      KGaA, Darmstadt, Germany.

Except for the historical information contained herein, this release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in the Forest Laboratories' SEC reports, including the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2006 and on Form 10-Q for the periods ended June 30, 2006, September 30, 2006
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:11/26/2014)... , Nov. 26, 2014   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... Ph.D., President and CEO of Regulus, will present a ... Jaffray Healthcare Conference at the New York Palace Hotel ... The presentation will be webcast at the time of ...
(Date:11/26/2014)... , Inc. (NASDAQ: BIOS ) announced today that ... at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference ... , Wednesday, December 3, 2014 , , , , Time: ... Location: , , , Boca Raton Resort and Club, Florida , ... BioScrip, Inc. is a leading national provider of infusion and ...
(Date:11/26/2014)... , Nov. 26, 2014 The medical ... a rate of 4%, with world market revenues ... Information. MRI and other types of medical imaging ... treatment of numerous medical conditions in children and ... techniques. Kalorama,s report, Medical Imaging Markets , ...
Breaking Medicine Technology:Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
... BROOKFIELD, Wis., March 1, 2012 The Food and ... to treat female urinary incontinence. "InTone ... the millions of women who have incontinence issues," said ... LLC, and inventor of InTone.  "With InTone, we believe ...
... the Pharmacy Technician Certification Board (PTCB) ... from the pharmacy profession on recommended changes to ... of specialty pharmacy technician exams and additional requirements ... period of practical experience, criminal background checks, and ...
Cached Medicine Technology:Medical Breakthrough for Incontinence From InControl Medical, LLC Cleared by FDA 2PTCB Calls For Profession-wide Feedback on Proposed Changes to Certification Program 2
(Date:11/28/2014)... Dr. Diane Walder, one of South ... to her practice called Ultrashape that is designed to help ... in just six weeks. Ultrashape has been praised by patients ... results when compared to other types of external fat reduction. ... said Dr. Walder. , According to Dr. Walder, Ultrashape ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 Dr. Paul Vitenas, ... will hold a Glitter & Glow Holiday Event for those in ... treatments offered at his practice. Glitter & Glow will take place ... Dr. Vitenas’ new location in the heart of Houston at 4208 ... of holidays and hope that you will come and celebrate the ...
(Date:11/28/2014)... Secura Consultants, based in Minneapolis, ... organizations in the country focused on delivering exemplary ... Secura Consultants is proud to offer complimentary Buy-Sell ... a leading global financial company. , Many businesses ... ownership interest comes the need for business succession ...
(Date:11/28/2014)... News) -- Celebration can quickly turn to tragedy ... experts say. Over the last decade, more than ... people were using turkey fryers, according to the U.S. ... for a patient who tried to deep fry the ... any circumstances," Dr. Arthur Sanford, a burn surgeon at ...
(Date:11/28/2014)... Alex Kramer HealthDay Reporter ... involved in the kitchen, through cooking classes or at home, ... to a recent review. Cooking programs and classes for ... according to the new research. And, although the review didn,t ... that such programs might help children develop long-lasting healthy habits. ...
Breaking Medicine News(10 mins):Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Want Kids to Eat Better? Get Them Cooking 2Health News:Want Kids to Eat Better? Get Them Cooking 3
... to determine how gender affects body,s reaction to HIV , ... may explain why HIV infection progresses faster to AIDS in ... say. , Their study found that a receptor molecule involved ... in women than in men. This then leads to differences ...
... , , , ... of St. Jude Children,s Research Hospital, has been invited to give ... , , The Leeuwenhoek Lecture, named ... the field of microbiology. Webster will present the lecture next summer. ...
... AURORA, Ohio, July 13 Arizona Cardinals 2008 NFC ... word to parents that vision problems can interfere with a child,s ... been told your child has perfect vision or 20/20 vision, your ... problem," warns Fitzgerald. , , Do ...
... tolerance to sudden hurts, , MONDAY, July 13 (HealthDay News) ... toe or experiencing some other painful incident? , Your ... , In a study that suggests bad words aren,t all ... hand in ice-cold water were able to withstand the frigid ...
... found that postmenopausal women who have taken a combined ... risk of developing progestin-accelerated breast tumors. Now, University of ... spice derived from the turmeric root, could reduce the ... therapy. "Approximately 6 million women in the United ...
... , , PARAMUS, N.J., July 13 Smart Balance, ... at www.smartbalance.com on August 6, 2009, at 9:30 ... at approximately 8:30 a.m. EDT the same day. The webcast will ... Investors and analysts may participate via conference call by dialing 1-800-895-0198 ...
Cached Medicine News:Health News:Immune Response May Speed AIDS Progression in Women 2Health News:St. Jude Virologist Honored by the Royal Society 2Health News:Larry Fitzgerald Offers Advice for Parents With Struggling Readers 2Health News:Larry Fitzgerald Offers Advice for Parents With Struggling Readers 3Health News:Larry Fitzgerald Offers Advice for Parents With Struggling Readers 4Health News:A Curse or Two Might Quell the Pain 2Health News:A Curse or Two Might Quell the Pain 3Health News:Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy 2
Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....
Viscoelastic Cannula, 23 g. Angled. 7 mm angled tip cannula with unique hub that facilitates flow of viscoelastic material. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 21 g., 8 mm from bend to tip. Overall length 25 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Medicine Products: